Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 5/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 9/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 8/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 7/20 | 0.43 |
| ▸ | DPP4 | P27487 | 5/20 | 0.43 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CTSH | P09668 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.37 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.37 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7592014 | 0.85 | CTSC (0.46) | CTSCDPP7DPP9DPP8DPP4 | |
| SCHEMBL7586126 | 0.82 | CTSC (0.44) | CTSCDPP7DPP9DPP8DPP4 | |
| SCHEMBL2182387 | 0.78 | DPP7 (0.57) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL9828439 | 0.78 | CTSC (0.57) | CTSCCYP1A2CYP3A4CTSHCYP2D6 | |
| SCHEMBL7613327 | 0.74 | DPP7 (0.58) | CTSCDPP7DPP9DPP8DPP4 | |
| SCHEMBL2182283 | 0.72 | CTSC (0.60) | CTSCCYP1A2CYP3A4CTSHCYP2D6 | |
| SCHEMBL10520841 | 0.72 | DPP7 (0.62) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL7588339 | 0.71 | MMP2 (0.43) | CTSCDPP7DPP9DPP8DPP4 | |
| SCHEMBL8721584 | 0.71 | DPP7 (0.58) | CTSCDPP7DPP9DPP8DPP4 | |
| SCHEMBL7591254 | 0.71 | HDAC8 (0.41) | CTSCDPP7DPP9DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030114362-A1 | Penta-or tetrapeptide binding to somatostatin receptors and the use of the same | NOVASPIN BIOTECH GMBH (DE) | 2003-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114362-A1 | Penta-or tetrapeptide binding to somatostatin receptors and the use of the same | SSTR5, SSTR3, SCTR | CTSC 83/4885DPP7 191/4885DPP9 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.